Product Information
SEVELAMER HCL 800 MG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.7453 per EA under NDC 70748017326. Its NADAC has been published 222 times since Mar 30, 2022.
Strength
800 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
70748017326
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
SEVELAMER HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA213145On Market Since
2/25/2022
Pharmacological Classes
Price Statistics
The NADAC for SEVELAMER HCL 800 MG TABLET has been published 222 times since Mar 30, 2022, and over the history we have for it it has declined 83.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7453 per EA |
|---|---|
| All-time high | $4.8175 (Jul 13, 2022) |
| All-time low | $0.7453 (Jun 17, 2026) |
| 52-week high | $1.3679 |
| 52-week low | $0.7453 |
| Median price | $1.8740 |
| Average price | $2.0750 |
| Largest weekly change | -37.7% (May 22, 2024) |
| Weeks tracked | 222 |
| Tracking since | Mar 30, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Sevelamer hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of SEVELAMER HCL 800 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SEVELAMER HCL 800 MG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $0.7453 per EA (NDC 70748017326), effective Jun 24, 2026.
How has the price of SEVELAMER HCL 800 MG TABLET changed over time?
Over the history we have for it, the NADAC for SEVELAMER HCL 800 MG TABLET has declined 83.5%. It has been tracked across 222 weekly CMS publications since Mar 30, 2022.
What are the highest and lowest recorded NADAC prices for SEVELAMER HCL 800 MG TABLET?
Since Mar 30, 2022, the NADAC for SEVELAMER HCL 800 MG TABLET has ranged from a low of $0.7453 (Jun 17, 2026) to a high of $4.8175 (Jul 13, 2022), with a median of $1.8740 per EA.
Are there cheaper alternatives to SEVELAMER HCL 800 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of SEVELAMER HCL 800 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures SEVELAMER HCL 800 MG TABLET?
SEVELAMER HCL 800 MG TABLET (NDC 70748017326) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification